LEXINGTON, Mass., March 12, 2026 /PRNewswire/ — Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948),…
Inc.’s annual Female Founders list celebrates the nation’s most innovative women entrepreneurs, who collectively generated approximately $12.3 billion in 2025…
Highlights initiatives to advance competitive positioning and drive shareholder value through cycles Announces additional $2.2B share repurchase authorization program, bringing…